ES2526905T3 - Hidrogeles poliméricos y uso de los mismos - Google Patents
Hidrogeles poliméricos y uso de los mismos Download PDFInfo
- Publication number
- ES2526905T3 ES2526905T3 ES12176918.6T ES12176918T ES2526905T3 ES 2526905 T3 ES2526905 T3 ES 2526905T3 ES 12176918 T ES12176918 T ES 12176918T ES 2526905 T3 ES2526905 T3 ES 2526905T3
- Authority
- ES
- Spain
- Prior art keywords
- polymeric hydrogel
- polymeric
- water
- polymer
- swelling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 195
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 212
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 103
- 238000000034 method Methods 0.000 claims abstract description 81
- 230000008961 swelling Effects 0.000 claims abstract description 68
- 238000004132 cross linking Methods 0.000 claims abstract description 46
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims abstract description 36
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 36
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims abstract description 35
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims abstract description 35
- 239000000243 solution Substances 0.000 claims abstract description 28
- 239000007864 aqueous solution Substances 0.000 claims abstract description 26
- 239000012153 distilled water Substances 0.000 claims abstract description 23
- 238000010438 heat treatment Methods 0.000 claims abstract description 19
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 74
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 74
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 68
- 238000006243 chemical reaction Methods 0.000 claims description 46
- 229920000831 ionic polymer Polymers 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 208000008589 Obesity Diseases 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 235000020824 obesity Nutrition 0.000 claims description 4
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 71
- 229920000642 polymer Polymers 0.000 description 56
- 235000015165 citric acid Nutrition 0.000 description 41
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 33
- 229940105329 carboxymethylcellulose Drugs 0.000 description 27
- 239000002253 acid Substances 0.000 description 24
- 229920002678 cellulose Polymers 0.000 description 24
- 235000010980 cellulose Nutrition 0.000 description 24
- 239000012530 fluid Substances 0.000 description 24
- 239000000203 mixture Substances 0.000 description 22
- 230000008569 process Effects 0.000 description 20
- 238000010521 absorption reaction Methods 0.000 description 18
- 239000001913 cellulose Substances 0.000 description 18
- 239000000463 material Substances 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 17
- 239000000499 gel Substances 0.000 description 16
- 150000008064 anhydrides Chemical class 0.000 description 14
- 239000000523 sample Substances 0.000 description 14
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 239000003431 cross linking reagent Substances 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- 235000013305 food Nutrition 0.000 description 13
- 229920001477 hydrophilic polymer Polymers 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 239000000600 sorbitol Substances 0.000 description 13
- 238000001157 Fourier transform infrared spectrum Methods 0.000 description 11
- -1 for example Polymers 0.000 description 11
- 239000002243 precursor Substances 0.000 description 11
- 125000006850 spacer group Chemical group 0.000 description 11
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000002250 absorbent Substances 0.000 description 9
- 230000002745 absorbent Effects 0.000 description 9
- 230000037406 food intake Effects 0.000 description 9
- 235000012631 food intake Nutrition 0.000 description 9
- 230000002496 gastric effect Effects 0.000 description 9
- 230000035484 reaction time Effects 0.000 description 9
- 210000000813 small intestine Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 238000001228 spectrum Methods 0.000 description 8
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 150000001718 carbodiimides Chemical class 0.000 description 6
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 229920013820 alkyl cellulose Polymers 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000002798 polar solvent Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000013270 controlled release Methods 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 125000002887 hydroxy group Chemical class [H]O* 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000036186 satiety Effects 0.000 description 4
- 235000019627 satiety Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 229920000896 Ethulose Polymers 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005102 attenuated total reflection Methods 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- QQVIHTHCMHWDBS-UHFFFAOYSA-N isophthalic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-N 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 229920002521 macromolecule Polymers 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 3
- 150000003628 tricarboxylic acids Chemical class 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007558 Cardiac failure chronic Diseases 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 229940122957 Histamine H2 receptor antagonist Drugs 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 229940069428 antacid Drugs 0.000 description 2
- 239000003159 antacid agent Substances 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920002988 biodegradable polymer Polymers 0.000 description 2
- 239000004621 biodegradable polymer Substances 0.000 description 2
- 239000006172 buffering agent Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229960002086 dextran Drugs 0.000 description 2
- PPQREHKVAOVYBT-UHFFFAOYSA-H dialuminum;tricarbonate Chemical compound [Al+3].[Al+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O PPQREHKVAOVYBT-UHFFFAOYSA-H 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 238000000113 differential scanning calorimetry Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001879 gelation Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 239000001341 hydroxy propyl starch Substances 0.000 description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920002959 polymer blend Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229940126409 proton pump inhibitor Drugs 0.000 description 2
- 239000000612 proton pump inhibitor Substances 0.000 description 2
- CYIDZMCFTVVTJO-UHFFFAOYSA-N pyromellitic acid Chemical compound OC(=O)C1=CC(C(O)=O)=C(C(O)=O)C=C1C(O)=O CYIDZMCFTVVTJO-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- NBAUUNCGSMAPFM-UHFFFAOYSA-N 3-(3,4-dicarboxyphenyl)phthalic acid Chemical compound C1=C(C(O)=O)C(C(=O)O)=CC=C1C1=CC=CC(C(O)=O)=C1C(O)=O NBAUUNCGSMAPFM-UHFFFAOYSA-N 0.000 description 1
- GEYAGBVEAJGCFB-UHFFFAOYSA-N 4-[2-(3,4-dicarboxyphenyl)propan-2-yl]phthalic acid Chemical compound C=1C=C(C(O)=O)C(C(O)=O)=CC=1C(C)(C)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GEYAGBVEAJGCFB-UHFFFAOYSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical group O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- ODBLHEXUDAPZAU-ZAFYKAAXSA-N D-threo-isocitric acid Chemical compound OC(=O)[C@H](O)[C@@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-ZAFYKAAXSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODBLHEXUDAPZAU-FONMRSAGSA-N Isocitric acid Natural products OC(=O)[C@@H](O)[C@H](C(O)=O)CC(O)=O ODBLHEXUDAPZAU-FONMRSAGSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940118662 aluminum carbonate Drugs 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229920006318 anionic polymer Polymers 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 235000020827 calorie restriction Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010889 donnan-equilibrium Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 238000003898 horticulture Methods 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 235000006796 hypocaloric diet Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002106 nanomesh Substances 0.000 description 1
- HDLRSIQOZFLEPK-UHFFFAOYSA-N naphthalene-1,2,5,8-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C2=C(C(O)=O)C(C(=O)O)=CC=C21 HDLRSIQOZFLEPK-UHFFFAOYSA-N 0.000 description 1
- DSCIZKMHZPGBNI-UHFFFAOYSA-N naphthalene-1,3,5,8-tetracarboxylic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C2=CC(C(=O)O)=CC(C(O)=O)=C21 DSCIZKMHZPGBNI-UHFFFAOYSA-N 0.000 description 1
- DOBFTMLCEYUAQC-UHFFFAOYSA-N naphthalene-2,3,6,7-tetracarboxylic acid Chemical compound OC(=O)C1=C(C(O)=O)C=C2C=C(C(O)=O)C(C(=O)O)=CC2=C1 DOBFTMLCEYUAQC-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960004872 nizatidine Drugs 0.000 description 1
- SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229960005019 pantoprazole Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000590 phytopharmaceutical Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000012704 polymeric precursor Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000012890 simulated body fluid Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N threo-D-isocitric acid Natural products OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 238000007492 two-way ANOVA Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/225—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B11/00—Preparation of cellulose ethers
- C08B11/20—Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/005—Crosslinking of cellulose derivatives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
- C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
- C08B15/04—Carboxycellulose, e.g. prepared by oxidation with nitrogen dioxide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/08—Cellulose derivatives
- C08J2301/26—Cellulose ethers
- C08J2301/28—Alkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
- Y02W30/00—Technologies for solid waste management
- Y02W30/40—Bio-organic fraction processing; Production of fertilisers from the organic fraction of waste or refuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Child & Adolescent Psychology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Colloid Chemistry (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20070584 | 2007-08-10 | ||
| PCT/IT2007/000584 WO2009022358A1 (en) | 2007-08-10 | 2007-08-10 | Superabsorbent polymer hydro gels and a method of preparing thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2526905T3 true ES2526905T3 (es) | 2015-01-16 |
Family
ID=39312966
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES12176918.6T Active ES2526905T3 (es) | 2007-08-10 | 2008-08-08 | Hidrogeles poliméricos y uso de los mismos |
| ES08785471.7T Active ES2554163T3 (es) | 2007-08-10 | 2008-08-08 | Hidrogeles poliméricos y uso de los mismos |
| ES12158633.3T Active ES2526788T3 (es) | 2007-08-10 | 2008-08-08 | Hidrogeles poliméricos y el uso médico de los mismos |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08785471.7T Active ES2554163T3 (es) | 2007-08-10 | 2008-08-08 | Hidrogeles poliméricos y uso de los mismos |
| ES12158633.3T Active ES2526788T3 (es) | 2007-08-10 | 2008-08-08 | Hidrogeles poliméricos y el uso médico de los mismos |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US8658147B2 (enExample) |
| EP (5) | EP2463308B1 (enExample) |
| JP (5) | JP5485151B2 (enExample) |
| CN (2) | CN101796075B (enExample) |
| AU (1) | AU2008286354B2 (enExample) |
| CA (1) | CA2695974C (enExample) |
| CY (2) | CY1115978T1 (enExample) |
| DK (2) | DK2463308T3 (enExample) |
| ES (3) | ES2526905T3 (enExample) |
| HR (1) | HRP20150121T1 (enExample) |
| HU (2) | HUE024123T2 (enExample) |
| MX (1) | MX2010001629A (enExample) |
| PL (2) | PL2463308T3 (enExample) |
| PT (2) | PT2463308E (enExample) |
| RU (2) | RU2493170C2 (enExample) |
| SI (2) | SI2532685T1 (enExample) |
| WO (2) | WO2009022358A1 (enExample) |
Families Citing this family (105)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2010001629A (es) * | 2007-08-10 | 2010-08-09 | Alessandro Sannino | Hidrogeles de polimero y metodos de preparacion de los mismos. |
| ES2626116T3 (es) * | 2008-11-18 | 2017-07-24 | Gelesis Llc | Métodos y composiciones para el control del peso y para mejorar el control glucémico |
| IT1393778B1 (it) | 2009-04-06 | 2012-05-08 | Sannino | Procedimento per il trattamento di rifiuti. |
| ES2671907T3 (es) * | 2010-01-13 | 2018-06-11 | Georg Bischof | Composición para la generación de una oclusión intestinal temporal |
| GB201000879D0 (en) * | 2010-01-20 | 2010-03-10 | Univ Reading The | Improved hydrogel synthesis |
| CN101983974B (zh) * | 2010-10-08 | 2014-07-16 | 青岛聚大洋海藻工业有限公司 | 食品添加剂g型褐藻胶提取及加工工艺 |
| RU2455007C1 (ru) * | 2010-11-01 | 2012-07-10 | Учреждение Белорусского государственного университета "Научно-исследовательский институт физико-химических проблем" | Способ получения гелеобразующих фосфатов декстрана |
| IT1404015B1 (it) * | 2011-02-04 | 2013-11-08 | Hsd Holding Smart Device S R L | Uso di un polimero di destrano reticolato come filtro contro l'inalazione di sostanze nocive per la salute |
| JP6135896B2 (ja) * | 2011-03-25 | 2017-05-31 | Jsr株式会社 | 高分子ゲル及びその製造方法 |
| WO2012148953A1 (en) * | 2011-04-25 | 2012-11-01 | Stc.Unm | Solid compositions for pharmaceutical use |
| US9760009B2 (en) * | 2011-05-13 | 2017-09-12 | Clarkson University | Cross-linked polymer based hydrogel material compositions, methods and applications |
| BR112013031209B1 (pt) * | 2011-06-07 | 2020-11-24 | Gelesis Llc | Metodo para produzir hidrogeis |
| JP2013129612A (ja) * | 2011-12-20 | 2013-07-04 | Kao Corp | 満腹感持続剤 |
| KR101212504B1 (ko) * | 2012-06-21 | 2012-12-24 | 염다원 | 황련추출물을 이용한 항균 하이드로겔 및 그 제조방법 |
| US9145340B2 (en) | 2012-08-13 | 2015-09-29 | Verdesian Life Sciences, Llc | Method of reducing atmospheric ammonia in livestock and poultry containment facilities |
| CN103724633A (zh) * | 2012-10-15 | 2014-04-16 | 中国科学院兰州化学物理研究所 | 一种粒状水凝胶 |
| US9961922B2 (en) | 2012-10-15 | 2018-05-08 | Verdesian Life Sciences, Llc | Animal feed and/or water amendments for lowering ammonia concentrations in animal excrement |
| RU2519927C1 (ru) * | 2013-01-18 | 2014-06-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Южно-Российский государственный университет экономики и сервиса" (ФГБОУ ВПО "ЮРГУЭС") | Теплосъемная конструкция одежды |
| ITRM20130088A1 (it) * | 2013-02-14 | 2014-08-15 | Jaber Innovation S R L | Idrogeli biodegradabili superassorbenti |
| JP6342990B2 (ja) * | 2013-04-12 | 2018-06-13 | ダウ グローバル テクノロジーズ エルエルシー | メチルセルロースの水溶液を調製するための方法 |
| US10512957B2 (en) | 2013-08-02 | 2019-12-24 | Regenesis Bioremediation Products | Colloidal agents for aquifer and metals remediation |
| WO2015017820A1 (en) * | 2013-08-02 | 2015-02-05 | Regenesis Bioremediation Products | Colloidal agents for aquifer remediation |
| US11254620B2 (en) | 2013-08-05 | 2022-02-22 | Verdesian Life Sciences U.S., Llc | Micronutrient-enhanced polymeric seed coatings |
| TW201522390A (zh) | 2013-08-27 | 2015-06-16 | 特級肥料產品公司 | 聚陰離子聚合物 |
| WO2015035031A1 (en) | 2013-09-05 | 2015-03-12 | Verdesian Life Sciences, Llc | Polymer-boric acid compositions |
| SG11201605016SA (en) | 2013-12-20 | 2016-07-28 | Reliance Ind Ltd | Water absorbent polymers and a process for their preparation |
| WO2015097033A1 (en) * | 2013-12-23 | 2015-07-02 | Basf Se | Polysaccharide hydrogels |
| CN103788217B (zh) * | 2013-12-26 | 2016-05-11 | 昆明理工大学 | 一种纤维素凝胶材料、制备方法及用途 |
| WO2015157241A1 (en) * | 2014-04-10 | 2015-10-15 | Basf Se | Oral care compositions |
| CN103962111B (zh) * | 2014-05-08 | 2016-02-17 | 闽江学院 | 阳离子水凝胶材料 |
| WO2015179687A1 (en) | 2014-05-21 | 2015-11-26 | Verdesian Life Sciences, Llc | Polymer soil treatment compositions including humic acids |
| CA2946202C (en) | 2014-05-22 | 2022-06-21 | Verdesian Life Sciences, Llc | Polymeric compositions |
| KR20230085212A (ko) | 2014-06-20 | 2023-06-13 | 젤레시스 엘엘씨 | 과체중 또는 비만 치료 방법 |
| RU2709361C2 (ru) | 2015-01-29 | 2019-12-17 | Джелезис Ллк | Способ получения гидрогелей, характеризующихся сочетанием высокого модуля упругости и высокой абсорбционной способности |
| JP6983073B2 (ja) | 2015-05-18 | 2021-12-17 | ザイムトロニクス インコーポレイテッド | 磁気固定化殺菌性酵素 |
| WO2016201230A1 (en) | 2015-06-10 | 2016-12-15 | Rhodia Operations | Phosphonated polysaccharides and gels and process for making same |
| EP3323166B1 (en) | 2015-07-15 | 2024-03-13 | ZYMtronix, Inc. | Automated bionanocatalyst production |
| EP3144340A1 (en) * | 2015-09-17 | 2017-03-22 | Solvay Acetow GmbH | Polymer gels, method of preparation and uses thereof |
| WO2017061166A1 (ja) * | 2015-10-05 | 2017-04-13 | ユニ・チャーム株式会社 | 生分解性吸水剤およびその製法 |
| JP6407204B2 (ja) * | 2015-10-05 | 2018-10-17 | ユニ・チャーム株式会社 | 生分解性吸水剤およびその製法 |
| CA3012698A1 (en) | 2016-02-05 | 2017-08-10 | Entrega Inc. | Oral dosage form with drying agent for delivery of active agent |
| WO2017180383A1 (en) * | 2016-04-16 | 2017-10-19 | Zymtronix, Llc | Magnetic macroporous polymeric hybrid scaffolds for immobilizing bionanocatalysts |
| EP3448365A4 (en) * | 2016-04-25 | 2019-12-25 | Gelesis, LLC. | METHOD FOR TREATING CONSTRUCTION |
| CN105860107B (zh) * | 2016-04-26 | 2018-02-09 | 中南大学 | 一种过氧化氢响应及具有电化学活性的壳聚糖水凝胶的制备方法 |
| JP7178341B2 (ja) * | 2016-08-01 | 2022-11-25 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | タンパク質およびペプチドの送達のための粒子 |
| RU175482U1 (ru) * | 2016-08-04 | 2017-12-06 | Федеральное государственное бюджетное учреждение науки Институт высокомолекулярных соединений Российской академии наук | Исполнительное устройство |
| CN109788762B (zh) | 2016-08-13 | 2023-07-11 | 齐姆特罗尼克斯催化系统股份有限公司 | 磁性固定化的杀生物酶和杀生物化学品 |
| SE1651136A1 (en) * | 2016-08-24 | 2018-02-25 | Organoclick Ab | Bio-based pec compositions as binders for fiber based materials, textiles, woven and nonwoven materials |
| MX393642B (es) * | 2016-09-23 | 2025-03-21 | Barrera Jr Michael O Sullivan | Estructura reticular para la regeneracion e ingenieria de tejido y su proceso de síntesis |
| WO2018087272A1 (en) * | 2016-11-11 | 2018-05-17 | Anteis S.A. | Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof |
| WO2018094290A1 (en) * | 2016-11-18 | 2018-05-24 | Tissuevision, Inc. | Automated tissue section capture, indexing and storage system and methods |
| US10448970B2 (en) | 2016-12-05 | 2019-10-22 | Daniel E. Walzman | Alternative use for hydrogel intrasaccular occlusion device with telescoping central support element |
| US20180206848A1 (en) | 2016-12-05 | 2018-07-26 | Daniel E. Walzman | Alternative Use for Hydrogel Intrasaccular Occlusion Device with Radial Bars for Structural Support |
| CA3055985A1 (en) | 2017-03-22 | 2018-09-27 | Genentech, Inc. | Hydrogel cross-linked hyaluronic acid prodrug compositions and methods |
| WO2018187404A1 (en) | 2017-04-05 | 2018-10-11 | Gelesis, Llc | Improved superabsorbent materials and methods of production thereof |
| MX2019012086A (es) * | 2017-04-14 | 2021-01-08 | Gelesis Llc | Composiciones y métodos para tratar o prevenir trastornos relacionados con la permeabilidad intestinal. |
| FR3068039B1 (fr) | 2017-06-22 | 2020-07-10 | Jellynov | Composition auto-moussante en milieu acide et procede de preparation |
| GB201711644D0 (en) | 2017-07-19 | 2017-08-30 | Satie8 Ltd | Polymer Compositions |
| AU2018307478B2 (en) | 2017-07-28 | 2024-02-01 | Kimberly-Clark Worldwide, Inc. | Absorbent article containing nanoporous superabsorbent particles |
| WO2019023060A2 (en) * | 2017-07-28 | 2019-01-31 | Kimberly-Clark Worldwide, Inc. | NANOPOROUS SUPERABSORBENT PARTICLES |
| US11596592B2 (en) | 2017-09-19 | 2023-03-07 | Lg Household & Health Care Ltd. | Hyaluronic acid filler using microneedle patch |
| IT201700105979A1 (it) * | 2017-09-21 | 2019-03-21 | Giacomo Guerrini | Biodegradable polymer-clay composite - Composito polimerico-argilloso biodegradabile |
| CN108003391A (zh) * | 2017-12-01 | 2018-05-08 | 武汉理工大学 | 一种全多糖衍生物基超吸水凝胶及其制备方法和应用 |
| DE112017008257A5 (de) | 2017-12-07 | 2020-09-24 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur vernetzung von polymeren mit nucleophilen funktionalitäten, vernetzte polymere sowie verwendungen hiervon |
| CN108354166A (zh) * | 2018-02-06 | 2018-08-03 | 吉林农业大学 | 一种高膳食纤维玉米淀粉凝胶及其制备方法 |
| BR112020017030A2 (pt) * | 2018-02-20 | 2020-12-15 | Advanced Aesthetic Technologies, Inc. | Hidrogéis de alta concentração e métodos relacionados |
| JP7445600B2 (ja) | 2018-04-02 | 2024-03-07 | ポリグリーン リミテッド | スチレンマレイン酸コポリマーおよびバイオポリマーに基づく負荷下で高吸収性を有する生分解性超吸収性ポリマーの製造方法 |
| KR102294696B1 (ko) * | 2018-06-27 | 2021-08-30 | 킴벌리-클라크 월드와이드, 인크. | 나노기공 초흡수성 입자 |
| US20210362125A1 (en) * | 2018-06-27 | 2021-11-25 | Kimberly-Clark Worldwide, Inc. | Absorbent article containing nanoporous superabsorbent particles |
| CN110732037B (zh) | 2018-07-20 | 2023-05-26 | 广州倍绣生物技术有限公司 | 止血糊剂及其制备方法 |
| CN110064344B (zh) * | 2018-09-07 | 2023-03-28 | 中北大学 | 具有高热稳定性的叶酸超分子有机凝胶 |
| EP3880770B1 (en) | 2018-11-13 | 2023-08-09 | Polygreen Ltd. | Polymeric composition for use as soil conditioner with improved water absorbency during watering of the agricultural crops |
| FR3089224B1 (fr) | 2018-12-04 | 2020-12-11 | Jellynov | Composition auto-moussante en milieu acide et procédé de préparation |
| SG11202108457UA (en) * | 2019-02-06 | 2021-09-29 | Tearclear Corp | Systems and methods for preservative removal from ophthalmic formulations comprising complexing agents |
| CN109675096B (zh) * | 2019-02-21 | 2021-03-12 | 武汉纺织大学 | 一种壳聚糖纤维水凝胶敷料的制备方法 |
| CN111187429B (zh) * | 2019-06-18 | 2020-08-14 | 吾奇生物医疗科技(镇江)有限公司 | 双交联胶原水凝胶材料、其制备方法与应用 |
| CN110496135B (zh) * | 2019-09-27 | 2022-02-01 | 南京易亨制药有限公司 | 一种用于减肥的组合物 |
| JP7616696B2 (ja) | 2019-09-30 | 2025-01-17 | ジョージア テック リサーチ コーポレイション | 高い酸素および水蒸気バリア特性を有する熱架橋ポリ（グルクロン酸）－キトサンフィルム |
| CN113423386A (zh) * | 2019-10-01 | 2021-09-21 | 美国倍利年制药有限公司 | 治疗或预防肥胖和体重管理的方法 |
| AU2020405238A1 (en) | 2019-12-19 | 2022-07-14 | TearClear Corp. | Preservative removal from eye drops |
| CN111218013B (zh) * | 2020-01-22 | 2022-08-23 | 上海应用技术大学 | 一种交联聚合物的制备方法及其应用 |
| US20230220177A1 (en) * | 2020-05-20 | 2023-07-13 | Nouryon Chemicals International B.V. | Thermally expandable cellulose-based microspheres having low expansion temperatures |
| RU2743941C1 (ru) * | 2020-07-29 | 2021-03-01 | Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) | Способ получения биополимерного гидрогеля |
| CN112341672B (zh) * | 2020-10-22 | 2022-03-04 | 爱美客技术发展股份有限公司 | 一种修饰的交联羧甲基纤维素凝胶及其制备方法 |
| EP4237020A4 (en) | 2020-10-30 | 2024-11-06 | Kimberly-Clark Worldwide, Inc. | NANOPOROUS SUPERABSORBENT PARTICLES WITH LOW NON-SOLVENTS |
| CN112263563A (zh) * | 2020-11-03 | 2021-01-26 | 吴良平 | 一种具有通便功能的水凝胶及其制备方法与应用 |
| CN112262984B (zh) * | 2020-11-03 | 2021-12-14 | 吴良平 | 一种辅助控制饮食的水凝胶及其制备方法与应用 |
| CN112876307B (zh) * | 2021-01-21 | 2022-09-20 | 西北师范大学 | 一种具有缓释氮肥作用的可降解高吸水树脂及其制备方法 |
| CN112915974A (zh) * | 2021-02-05 | 2021-06-08 | 青岛科技大学 | 苹果酸-壳聚糖纳米孔水凝胶微球及其制备方法及应用 |
| RU2766223C1 (ru) * | 2021-03-10 | 2022-02-10 | Федеральное государственное бюджетное учреждение науки Институт химии Дальневосточного отделения Российской академии наук (ИХ ДВО РАН) | Способ получения биополимерных пленок |
| CN116003830B (zh) * | 2021-03-23 | 2025-01-21 | 厦门君德医药科技有限公司 | 超吸收性水凝胶及其制备方法和应用 |
| CN116509842B (zh) * | 2021-09-09 | 2024-09-20 | 厦门君德医药科技有限公司 | 药物组合物及其制备方法和应用 |
| CN113854567A (zh) * | 2021-09-28 | 2021-12-31 | 至睿生物(江苏)有限公司 | 一种可食用水凝胶及其制备方法和应用、包括可食用水凝胶的胃内填充剂 |
| CN114381014B (zh) * | 2021-12-16 | 2023-02-17 | 佑道(天津)健康咨询有限公司 | 一种可生物降解的水凝胶及其应用 |
| KR102441137B1 (ko) * | 2022-02-07 | 2022-09-06 | 김환철 | 분해속도 조절이 가능한 에테르기를 포함하는 생체적합성 고분자 하이드로겔 |
| CN114702734A (zh) * | 2022-04-08 | 2022-07-05 | 重庆师范大学 | 一种纤维素醚类凝胶及其制备方法和应用 |
| US20240084195A1 (en) * | 2022-09-12 | 2024-03-14 | Kannar Earth Science, Ltd. | Compositions and methods for improving soil condition |
| JP2024064675A (ja) * | 2022-10-28 | 2024-05-14 | 環テックス株式会社 | 新規イオン伝導性有機ゲル |
| CN116162289B (zh) * | 2022-12-06 | 2024-03-15 | 四川兴泰普乐医疗科技有限公司 | 多重交联羧甲基纤维素钠凝胶、制备方法、应用 |
| CN120958104A (zh) * | 2023-05-10 | 2025-11-14 | 乐天精密化学株式会社 | 环保型土壤改良剂及其制造方法 |
| GR1011001B (el) | 2023-11-22 | 2025-07-22 | Cloudpharm Private Company, | Υδρογελη για τη διαχειριση σωματικου βαρους |
| CN118436071B (zh) * | 2024-07-08 | 2024-11-12 | 浙江衡美健康科技股份有限公司 | 一种控制饮食及诱导饱腹感的水凝胶及其制备方法和应用 |
| CN119465616A (zh) * | 2024-10-30 | 2025-02-18 | 华南理工大学 | 一种交联型纤维素基干态吸水织物及其制备方法与应用 |
| CN119386255B (zh) * | 2024-10-31 | 2025-06-27 | 深圳市龙岗区第二人民医院 | 一种抗菌纤维素水凝胶敷料及其制备方法 |
| CN119144018B (zh) * | 2024-11-12 | 2025-03-07 | 浙江农林大学 | 一种抗溶胀、水下黏附导电复合水凝胶及其制备方法与应用 |
Family Cites Families (83)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3526048A (en) | 1967-06-07 | 1970-09-01 | Us Agriculture | Cellulose fibers cross-linked and esterified with polycarboxylic acids |
| US3589364A (en) | 1968-03-14 | 1971-06-29 | Buckeye Cellulose Corp | Bibulous cellulosic fibers |
| FI793150A7 (fi) | 1978-10-12 | 1981-01-01 | Battelle Memorial Institute | Menetelmä karboksimetyliselluloosan ja saatujen tuotteiden ristikytkemiseksi. |
| JPS5885813A (ja) * | 1981-11-17 | 1983-05-23 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
| DD212969A1 (de) * | 1982-12-30 | 1984-08-29 | Adw Inst Polymerenchemie | Verfahren zur modifizierung von carboxymethylcellulose |
| ZA841044B (en) * | 1983-02-17 | 1984-09-26 | Merrell Dow Pharma | Dry mix cellulose ether compositions as bulk laxatives |
| DE3478445D1 (en) * | 1983-10-06 | 1989-07-06 | Kohjin Co | Process for preparing carboxymethyl ethyl cellulose suitable for enteric coating |
| JPS62141001A (ja) * | 1985-12-13 | 1987-06-24 | Dai Ichi Kogyo Seiyaku Co Ltd | 水不溶性のカルボキシアルキルセルロ−ス・アルカリ金属塩の製造方法 |
| US5047513A (en) * | 1986-07-10 | 1991-09-10 | Hoffmann-La Roche Inc. | Metal chelate resins |
| JPH0672106B2 (ja) * | 1987-04-22 | 1994-09-14 | 花王株式会社 | 緩下剤組成物 |
| IT1219587B (it) * | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | Polisaccaridi carbossiilici autoreticolati |
| DE3903672C1 (enExample) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
| US5190563A (en) * | 1989-11-07 | 1993-03-02 | The Proctor & Gamble Co. | Process for preparing individualized, polycarboxylic acid crosslinked fibers |
| US5137537A (en) | 1989-11-07 | 1992-08-11 | The Procter & Gamble Cellulose Company | Absorbent structure containing individualized, polycarboxylic acid crosslinked wood pulp cellulose fibers |
| CA2080224A1 (en) | 1990-04-18 | 1991-10-19 | Jindrich Kopecek | Colonic-targeted oral drug-dosage forms based on crosslinked hydrogels containing azobonds and exhibiting ph-dependent swelling |
| US5207934A (en) * | 1991-05-07 | 1993-05-04 | Union Oil Company Of California | Crosslinked hydroxyethylcellulose and its uses |
| US5111886A (en) * | 1991-05-07 | 1992-05-12 | Union Oil Company Of California | Crosslinked hydroxyethylcellulose and its uses |
| US5247072A (en) | 1991-10-25 | 1993-09-21 | Kimberly-Clark Corporation | Carboxyalkyl polysaccharides having improved absorbent properties and process for the preparation thereof |
| US5550189A (en) * | 1992-04-17 | 1996-08-27 | Kimberly-Clark Corporation | Modified polysaccharides having improved absorbent properties and process for the preparation thereof |
| HU220797B1 (hu) * | 1993-05-03 | 2002-05-28 | Chemische Fabrik Stockhausen Gmbh. | Polimer kompozíciók, depókészítmények, valamint eljárás ilyen kompozíciók előállítására és alkalmazására |
| FI955226A0 (fi) * | 1993-05-03 | 1995-11-01 | Stockhausen Chem Fab Gmbh | Polymeerikoostumuksia ja niiden valmistus, erityisesti absorptiomateriaaleja sekä niiden käyttö |
| JP3274550B2 (ja) | 1993-08-03 | 2002-04-15 | 株式会社日本触媒 | 吸水材の製法 |
| ES2127518T3 (es) | 1994-03-18 | 1999-04-16 | Procter & Gamble | Preparacion de fibras celulosicas individualizadas, reticuladas con acido policarboxilico. |
| WO1996002276A2 (en) * | 1994-07-18 | 1996-02-01 | Gel Sciences, Inc. | Novel polymer gel networks and methods of use |
| BR9509869A (pt) | 1994-12-09 | 1997-11-25 | Procter & Gamble | Composto absorvente e processo para produzir esse composto absorvente |
| US6060534A (en) * | 1996-07-11 | 2000-05-09 | Scimed Life Systems, Inc. | Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties |
| US20010006677A1 (en) | 1996-10-29 | 2001-07-05 | Mcginity James W. | Effervescence polymeric film drug delivery system |
| DE19654745C5 (de) * | 1996-12-30 | 2004-01-22 | Lechner, M.D., Prof. Dr. | Biologisch abbaubares Absorptionsmittel, dessen Herstellung und Verwendung |
| US6271278B1 (en) | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
| WO1998058686A1 (en) | 1997-06-24 | 1998-12-30 | SCA Mölnlycke AB | Absorbent polymer material based on renewable starting materials |
| US5948829A (en) * | 1997-11-25 | 1999-09-07 | Kimberly-Clark Worldwide, Inc. | Process for preparing an absorbent foam |
| CO5070628A1 (es) * | 1997-11-25 | 2001-08-28 | Kimberly Clark Co | Espuma absorbente que comprende un polimero, el producto absorbente que la comprende y el proceso para su preparacion |
| JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
| AU1908500A (en) | 1998-11-30 | 2000-06-19 | Hercules Incorporated | Controlled release carbohydrate embedded in a crosslinked polysaccharide |
| CA2356849C (en) * | 1998-12-16 | 2008-06-03 | Sca Hygiene Products Zeist B.V. | Acidic superabsorbent polysaccharides |
| US6471824B1 (en) | 1998-12-29 | 2002-10-29 | Weyerhaeuser Company | Carboxylated cellulosic fibers |
| JP2002537069A (ja) * | 1999-02-23 | 2002-11-05 | ファーソン メジカル インク． | 損傷の治療方法 |
| US6207699B1 (en) * | 1999-06-18 | 2001-03-27 | Richard Brian Rothman | Pharmaceutical combinations for treating obesity and food craving |
| US6867346B1 (en) * | 1999-09-21 | 2005-03-15 | Weyerhaeuser Company | Absorbent composite having fibrous bands |
| GB9924636D0 (en) * | 1999-10-18 | 1999-12-22 | Norgine Bv | Laxative preparation |
| EP1134232A1 (en) | 2000-03-16 | 2001-09-19 | SCA Hygiene Products AB | Polysaccharide-based superabsorbent film |
| WO2001087365A2 (en) * | 2000-05-15 | 2001-11-22 | Kimberly-Clark Worldwide, Inc. | Polysaccharide absorbent and method |
| US6475530B1 (en) * | 2000-05-31 | 2002-11-05 | Eric H. Kuhrts | Methods and compositions for producing weight loss |
| US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| CA2351253A1 (en) * | 2000-11-10 | 2002-05-10 | Groupe Lysac Inc./Lysac Group Inc. | Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent |
| US8263112B2 (en) * | 2000-11-20 | 2012-09-11 | Sorbent Therapeutics, Inc. | In vivo use of water absorbent polymers |
| EP1390085B1 (en) * | 2001-05-01 | 2009-08-05 | A.V. Topchiev Institute of Petrochemical Synthesis | Hydrogel compositions |
| DE10125599A1 (de) * | 2001-05-25 | 2002-11-28 | Stockhausen Chem Fab Gmbh | Superabsorber, Verfahren zu ihrer Herstellung und ihre Verwendung |
| ES2271287T3 (es) * | 2001-06-28 | 2007-04-16 | Basf Aktiengesellschaft | Hidrogeles acidos altamente capaces de hincharse. |
| AU2003234159A1 (en) * | 2002-04-22 | 2003-11-03 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
| JP4132993B2 (ja) * | 2002-06-03 | 2008-08-13 | 住友精化株式会社 | 吸水性樹脂およびその製造方法 |
| US7648619B2 (en) | 2002-06-04 | 2010-01-19 | Industrial Technology Research | Hydrogel-driven micropump |
| WO2004056343A1 (en) | 2002-12-19 | 2004-07-08 | Polymorfix, Inc. | Ingestible formulations for transient, noninvasive reduction of gastric volume |
| RU2005134364A (ru) | 2003-04-08 | 2006-06-10 | Проджиникс Фармасьютикалз, Инк. (Us) | Комбинированное лечение запора |
| EP1620076A4 (en) * | 2003-04-25 | 2010-08-25 | Kos Life Sciences Inc | HIGH SUPERPOREOUS HYDROGEL FORMATION |
| US20050005870A1 (en) * | 2003-07-11 | 2005-01-13 | The Clorox Company | Composite absorbent particles |
| JP5448297B2 (ja) | 2003-10-16 | 2014-03-19 | テクコム・グループ・リミテッド・ライアビリティ・カンパニー | 低減した血中応答を有する低減可消化炭水化物食物 |
| US8128958B2 (en) | 2003-11-10 | 2012-03-06 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
| US20050143571A1 (en) * | 2003-12-30 | 2005-06-30 | Weyerhaeuser Company | Method for forming individualized intrafiber crosslinked cellulosic fibers with improved brightness and color |
| TW200533391A (en) * | 2004-03-25 | 2005-10-16 | Sun Pharmaceutical Ind Ltd | Gastric retention drug delivery system |
| US8580953B2 (en) * | 2004-06-21 | 2013-11-12 | Evonik Degussa Gmbh | Water-absorbing polysaccharide and method for producing the same |
| CA2588147A1 (en) | 2004-12-08 | 2006-06-15 | Unilever Plc | Satiety enhancing food product and a method for manufacturing such |
| US20070059350A1 (en) * | 2004-12-13 | 2007-03-15 | Kennedy John P | Agents for controlling biological fluids and methods of use thereof |
| US7541396B2 (en) * | 2004-12-29 | 2009-06-02 | Weyerhaeuser Nr Company | Method for making carboxyalkyl cellulose |
| US20060142480A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Method of making carboxyalkyl cellulose polymer network |
| US7300965B2 (en) * | 2004-12-29 | 2007-11-27 | Weyerhaeuser Company | Mixed polymer network |
| ITTO20040918A1 (it) * | 2004-12-29 | 2005-03-29 | Luigi Ambrosio | Idrogel polimerici superassorbenti biodegradabili e procedimento per la loro preparazione |
| US20060142478A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose polymer network |
| US20060142561A1 (en) * | 2004-12-29 | 2006-06-29 | Mengkui Luo | Carboxyalkyl cellulose |
| FR2882366B1 (fr) * | 2005-02-18 | 2008-04-18 | Coletica Sa | Polymere reticule de carbohydrate, notamment a base de polysaccharides et/ou de polyols |
| BRPI0708842A2 (pt) | 2006-03-28 | 2011-06-14 | Gelesis Inc | uso de materiais polimÉricos com outras substÂncias para aumento do desempenho |
| BRPI0709891A2 (pt) | 2006-03-30 | 2011-07-26 | Gelesis Inc | materiais polimÉricos como enchimento do estâmago e sua preparaÇço |
| AU2007233110B2 (en) | 2006-03-30 | 2011-12-22 | Exotech Bio Solutions Ltd. | Polymeric materials as stomach filler and their preparation |
| US20080075785A1 (en) * | 2006-09-22 | 2008-03-27 | San-Laung Chow | Controlled release hydrogel formulation |
| US20080147026A1 (en) * | 2006-12-15 | 2008-06-19 | Jian Qin | Absorbent fiber with a low absorbent capacity and slow absorption rate |
| JP2008285611A (ja) * | 2007-05-18 | 2008-11-27 | Daicel Chem Ind Ltd | 架橋ゲルの製造方法及びその架橋ゲル |
| MX2010001629A (es) * | 2007-08-10 | 2010-08-09 | Alessandro Sannino | Hidrogeles de polimero y metodos de preparacion de los mismos. |
| US8039683B2 (en) * | 2007-10-15 | 2011-10-18 | Kimberly-Clark Worldwide, Inc. | Absorbent composites having improved fluid wicking and web integrity |
| ES2626116T3 (es) | 2008-11-18 | 2017-07-24 | Gelesis Llc | Métodos y composiciones para el control del peso y para mejorar el control glucémico |
| BR112013031209B1 (pt) * | 2011-06-07 | 2020-11-24 | Gelesis Llc | Metodo para produzir hidrogeis |
| KR20230085212A (ko) * | 2014-06-20 | 2023-06-13 | 젤레시스 엘엘씨 | 과체중 또는 비만 치료 방법 |
| RU2709361C2 (ru) * | 2015-01-29 | 2019-12-17 | Джелезис Ллк | Способ получения гидрогелей, характеризующихся сочетанием высокого модуля упругости и высокой абсорбционной способности |
| EP3448365A4 (en) | 2016-04-25 | 2019-12-25 | Gelesis, LLC. | METHOD FOR TREATING CONSTRUCTION |
-
2007
- 2007-08-10 MX MX2010001629A patent/MX2010001629A/es active IP Right Grant
- 2007-08-10 WO PCT/IT2007/000584 patent/WO2009022358A1/en not_active Ceased
-
2008
- 2008-08-08 ES ES12176918.6T patent/ES2526905T3/es active Active
- 2008-08-08 PT PT121586333T patent/PT2463308E/pt unknown
- 2008-08-08 PL PL12158633T patent/PL2463308T3/pl unknown
- 2008-08-08 PT PT121769186T patent/PT2532685E/pt unknown
- 2008-08-08 CN CN200880104399.0A patent/CN101796075B/zh active Active
- 2008-08-08 SI SI200831372T patent/SI2532685T1/sl unknown
- 2008-08-08 EP EP20120158633 patent/EP2463308B1/en active Active
- 2008-08-08 AU AU2008286354A patent/AU2008286354B2/en active Active
- 2008-08-08 EP EP20120176381 patent/EP2514444A1/en not_active Withdrawn
- 2008-08-08 DK DK12158633.3T patent/DK2463308T3/en active
- 2008-08-08 EP EP20120176382 patent/EP2535359A1/en not_active Withdrawn
- 2008-08-08 PL PL12176918T patent/PL2532685T3/pl unknown
- 2008-08-08 CN CN201410126564.XA patent/CN104327191A/zh active Pending
- 2008-08-08 ES ES08785471.7T patent/ES2554163T3/es active Active
- 2008-08-08 DK DK12176918T patent/DK2532685T3/en active
- 2008-08-08 EP EP20120176918 patent/EP2532685B1/en active Active
- 2008-08-08 SI SI200831356T patent/SI2463308T1/sl unknown
- 2008-08-08 HU HUE12176918A patent/HUE024123T2/en unknown
- 2008-08-08 CA CA2695974A patent/CA2695974C/en active Active
- 2008-08-08 JP JP2010520475A patent/JP5485151B2/ja active Active
- 2008-08-08 ES ES12158633.3T patent/ES2526788T3/es active Active
- 2008-08-08 EP EP08785471.7A patent/EP2178922B1/en active Active
- 2008-08-08 WO PCT/EP2008/006582 patent/WO2009021701A2/en not_active Ceased
- 2008-08-08 RU RU2010105385/04A patent/RU2493170C2/ru active
- 2008-08-08 HU HUE12158633A patent/HUE024121T2/en unknown
-
2010
- 2010-02-10 US US12/703,286 patent/US8658147B2/en active Active
-
2013
- 2013-06-13 RU RU2013126920A patent/RU2641749C2/ru active
- 2013-11-18 JP JP2013238364A patent/JP5760069B2/ja active Active
-
2014
- 2014-01-08 US US14/150,430 patent/US20140296507A1/en not_active Abandoned
-
2015
- 2015-02-02 HR HRP20150121TT patent/HRP20150121T1/hr unknown
- 2015-02-02 CY CY20151100108T patent/CY1115978T1/el unknown
- 2015-02-02 CY CY20151100109T patent/CY1115980T1/el unknown
- 2015-06-08 JP JP2015115944A patent/JP2015212388A/ja active Pending
-
2016
- 2016-06-17 US US15/185,443 patent/US10086014B2/en active Active
-
2017
- 2017-09-14 JP JP2017176735A patent/JP7027083B2/ja active Active
-
2019
- 2019-08-21 US US16/546,722 patent/US20200046755A1/en not_active Abandoned
-
2020
- 2020-01-10 JP JP2020002831A patent/JP2020097741A/ja not_active Withdrawn
-
2021
- 2021-05-28 US US17/333,424 patent/US20210353665A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2526905T3 (es) | Hidrogeles poliméricos y uso de los mismos | |
| ES2693236T3 (es) | Método para la producción de hidrogeles | |
| US11020421B2 (en) | Superabsorbent materials and methods of production thereof | |
| AU2016219713B2 (en) | Polymer hydrogels and methods of preparation thereof | |
| AU2013204055C1 (en) | Polymer hydrogels and methods of preparation thereof | |
| HK1172633B (en) | Polymer hydrogels and medical use thereof | |
| HK1147101A (en) | Polymer hydrogels and methods of preparation thereof |